Compare QURE & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | GRBK |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Netherlands | United States |
| Employees | 248 | 620 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2013 | 2006 |
| Metric | QURE | GRBK |
|---|---|---|
| Price | $22.42 | $64.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $61.24 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 307.7K |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 3.09 |
| Revenue | $13,107,000.00 | ★ $2,098,471,000.00 |
| Revenue This Year | $54.78 | N/A |
| Revenue Next Year | $356.14 | $1.59 |
| P/E Ratio | ★ N/A | $21.03 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $59.12 |
| 52 Week High | $71.50 | $83.18 |
| Indicator | QURE | GRBK |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 49.99 |
| Support Level | $22.32 | $60.69 |
| Resistance Level | $25.61 | $74.50 |
| Average True Range (ATR) | 1.19 | 1.87 |
| MACD | 0.75 | 0.34 |
| Stochastic Oscillator | 57.58 | 62.81 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.